ImmunOs Therapeutics Appoints Jeffrey Abbey as Chief Operating Officer, Establishes Clinical Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Versameb Announces Management Update
- Dr Klaas Zuideveld appointed as Chief Executive Officer to accelerate the development of Versameb s lead pipeline products
- Co-founder Prof Friedrich Metzger assumes role of Chief Scientific Officer to focus on leveraging the unique VERSagile RNA platform in the drive to realize its broad potential
News provided by
Share this article
Share this article
BASEL, Switzerland, Jan. 8, 2021 /PRNewswire/ Versameb AG ( Versameb ), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, announces the appointment of Dr Klaas Zuideveld as Chief Executive Officer (CEO). Prof Friedrich Metzger will move back to the role of Chief Scientific Officer (CSO) to focus on developing Versameb s innovative VERS